Introduction It has previously been shown that an increased number of antibodies against
citrullinated peptides/proteins (ACPA) predate the onset of rheumatoid arthritis (RA). Over …

Figure 1 Changes in autoantibody response over time:(A) percentage of patients with
seroconversion to positive in patients negative for all autoantibodies at baseline,(B) …

The prognostic value of two antibodies targeting citrullinated antigens, anti-Sa and anti-
cyclic citrullinated peptide (CCP), present at inclusion, was evaluated prospectively in a …

Objective To determine whether anti–apolipoprotein A‐1 (anti–Apo A‐1) IgG are associated
with major cardiovascular events in patients with rheumatoid arthritis (RA). Methods We …

With great interest, we read the recently published report by Myasoedova et al in which a
significant increase in incidence of rheumatoid factor (RF)-negative rheumatoid arthritis (RA) …

In recent years, several papers have been published on cardiovascular (CV) involvement,
risk, management, and treatment in systemic inflammatory arthritis (SIA), including …

Objective. Inflammation and autoimmunity are associated with increased cardiovascular
(CV) risk in patients with rheumatoid arthritis. This association may also be present in those …

Introduction Patients with rheumatoid arthritis (RA) have increased risk of cardiovascular
(CV) events. We sought to test the hypothesis that due to increased inflammation, CV …

Background: Many rheumatoid arthritis (RA) patients experience an asymptomatic phase
preceding clinical onset of disease, in which antibodies against citrullinated proteins (aCCP …

Objective The novel description of antibodies to lipoprotein lipase (anti‐LPL) associated with
dyslipoproteinemia prompted us to analyze the association of anti‐LPL with clinical and …